MALAT1 and non-small cell lung carcinoma: MALAT1 (metastasis-associated lung adenocarcinoma transcript 1) is associated with metastatic potential of NSCLC, while TUG1 can affect immune checkpoint molecules, potentially influencing immunotherapy responses [6,12,13].